| Website | tethysbio.com |
| Category | BioTech |
| Phone | 510-420-6700 |
| Employees | |
| Founded | 2002 |
| Description | Biological Markers for Diagnoses |
| Lipomics Technologies, 9/08 |
| Series D, 11/09 Aeris Capital Wasatch Advisors Intel Capital Kleiner Perkins Caufield & Byers Mohr Davidow Ventures | $25M |
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.
